Structural and Functional Abnormalities in the Caudate Nucleus of Schizophrenic Patients with and without Obsessive Symptoms by Mohamed A El Hadidy. et al.
Middle East Current Psychiatry
 
Structural and Functional Abnormalities in the Caudate Nucleus of Schizophrenic
Patients with and without Obsessive Symptoms
--Manuscript Draft--
 
Manuscript Number: MECPsych-D-14-00033R1
Full Title: Structural and Functional Abnormalities in the Caudate Nucleus of Schizophrenic
Patients with and without Obsessive Symptoms
Short Title: Caudate Nucleus in Schizophrenic Patients with and without Obsessive Symptoms
Article Type: Original Article
Keywords: Schizophrenia, obsessive compulsive symptoms, caudate volume, magnetic
resonance spectroscopy
Corresponding Author: ahmed elmogy, ph.d
mansoura university
EGYPT
Corresponding Author Secondary
Information:
Corresponding Author's Institution: mansoura university
Corresponding Author's Secondary
Institution:
First Author: Mohamed El-Hadidy
First Author Secondary Information:
Order of Authors: Mohamed El-Hadidy
ahmed elmogy, ph.d
Tamer Belal
Sherine El Mously
Noha El Saba
Galal El Hawary
Order of Authors Secondary Information:
Manuscript Region of Origin: EGYPT
Abstract: Background: Obsessive compulsive symptoms (OCS)  have been frequently described
in schizophrenic populations. There is a controversy on whether this co-occurrence is
more than just co-morbidity or represents a distinct subgroup in schizophrenia. Aim of
the work: to investigate if there are possible underlying structural and functional
differences between the schizophrenic patients with and without OCS. Methodology:
participants in this study were divided into 3 groups: 20 patients having schizophrenia
with OCS; 20 patients having schizophrenia without OCS (both were diagnosed
according to DSM-IV-TR); and 20 matching controls. All subjects underwent a
magnetic resonance imaging for volumetric measurement of the caudate nucleus; and
a magnetic resonance spectroscopy (MRS) to measure choline (Cho), creatine (Cr)
and N-acetyl aspartate (NAA) in the caudate nucleus. Results: Caudate volume was
found to be reduced in either schizophrenic patients with or without OCS (P≤ 0.05).
MRS findings showed that the schizophrenic patients without OCS have significant
increase in Cho concentration (P≤ 0.05) while, they have average NAA concentration.
On the other hand, schizophrenic patients with OCS had significant reduction in NAA
concentration (P≤ 0.05) with average Cho concentration. Conclusion: Schizophrenic
patients with OCS may have an atypical set of neuro-radiological characteristics which
would specifically categorize it within the schizophrenia spectrum.
Response to Reviewers:
1- Title: we changed the title
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
2- Aim of the study: we changed and completed it
3- In Patients and Methods:
* In exclusion criteria: what are the organic brain disorders: examples are listed
* Where your 3 groups age and sex-matched? We stated it
* Diagnosis according to DSM-IV-TR
* In Magnetic Resonance Spectroscopy (MRS):
What does the abbreviation ppm mean? parts per million
4- Statistical analysis: standard deviation is corrected
5- Results:
* Standard Deviation are added between the brackets
* Stars are correctly placed with significance below the tables
6- Discussion:Grammar is revised
* Concentration is completed as a word
7- References:
We updated the references
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Ahmed El Mogy 
MBBCh, MSc, MD 
Lecturer of Psychiatry 
Mansoura University 
Mansoura, Egypt 
Dear Prof. Asaad, 
 
Please find enclosed a manuscript entitled "Structural and Functional Abnormalities 
in the Caudate Nucleus of Schizophrenic Patients with and without Obsessive 
Symptoms" that we wish to submit as an original article for publication in your 
honorable journal "Middle East Current Psychiatry" 
 
The study reported in this paper has been approved by the medical ethical committee 
of the Mansoura University and we have received the patients' consent as stated in the 
Methods section.  
 
Our study aimed to investigate if there are possible underlying structural and 
functional differences between the schizophrenic patients with or without obsessive 
compulsive symptoms. 
We believe that this will be an original addition to our knowledge in Neuropsychiatry 
by understanding some neuro-radiological aspects of schizophrenic patients with or 
without obsessive compulsive symptoms. 
 
We confirm that this manuscript has not been published elsewhere and is not under 
revision in any other journal. 
 
All authors have approved the manuscript and agree to its submission to Middle East 
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Structural and Functional Abnormalities in the Caudate Nucleus of 
Schizophrenic Patients with and without Obsessive Symptoms  
 
 
INTRODUCTION 
Obsessive compulsive symptoms (OCS) have been frequently described in 
schizophrenic populations (1). The prevalence of OCS in schizophrenia vary widely 
across the studies (10%–64%) (2). Several studies suggested increased rates of OCS 
and obsessive-compulsive disorder (OCD) among schizophrenic patients; up to 
proposing the existence of a distinct diagnostic sub-group of schizo-obsessive 
disorder (3). Whether this co-occurrence is more than just co-morbidity and represents 
a distinct subgroup still remains controversial (4). 
It has been described the presence of a disrupted cortico-striato-thalamo-cortical 
circuits in schizophrenic patients (5,6), and obsessive-compulsive disorder (OCD) 
patients (7,8). Magnetic resonance imaging (MRI) and magnetic resonance 
spectroscopy (MRS) are non-invasive in vivo methods that allow studying these 
functional circuits.  
The MRI allows a volumetric measurement of the basal ganglia structures including 
the caudate nucleus (9), while, the MRS provides useful information on the brain 
metabolites (10) such as  N-Acetyl aspartate (NAA) (11), choline (12) and creatine 
(13). Several studies showed disturbance in these metabolites in the caudate of 
schizophrenic patients (14, 15,16) and OCD patients (17,18).  
Manuscript (All Manuscript Text Pages in MS Word format, NO AUTHOR INFORMATION)
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Despite the early discovery of this co-morbidity, little attention has been paid to it. 
Consequently, researches regarding the precise underlying potential neurobiological 
mechanisms of this co-morbid condition have been limited (3)  
The aim of our study is to investigate if there are possible underlying structural and 
functional differences between the schizophrenic patients with or without OCS. 
SUBJECTS AND METHODS 
Our case control study was enrolled from January 2013 to January 2014 in the 
outpatient clinic of Mansoura University Hospitals. We included 
schizophrenic patients with and without OCS; and a control group of healthy 
persons. The study was approved by the medical ethical committee of 
Mansoura University and all subjects accepted to participate after giving 
either an oral or a written consent.  
Clinical assessment: 
All patients underwent a neuropsychiatric clinical interview including thorough 
history taking and examination by a psychiatrist and a neurologist. The diagnosis 
and the further sub-classification for presence or absence of OCS were done 
according to Diagnostic and Statistical Manual of Mental Disorders, Fourth 
division, Text Revised (DSM-IV-TR) criteria (19). The re-confirmation of the 
diagnosis was done by two blinded psychiatrists. We included all schizophrenic 
patients ranging from 15-50 years old from both sexes who are drug naïve (if on 
medication, it should be stopped for at least 4 weeks). We excluded patients with 
co-morbid mental retardation, organic brain disorders (such as ischemic vascular 
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diseases, brain tumors, trauma and degenerative disorders), substance use disorders 
and language or hearing difficulties. 
The patients were divided into: group (A): 20 schizophrenic patients with OCS, 
group (B): 20 schizophrenic patients without OCS; besides, a group (C): 20 control 
subjects of non psychiatric patients who came to Mansoura university hospital 
outpatient clinic and some workers in the hospitals. The control group is matching 
in age and sex with the above mentioned groups of patients.  
Imaging Studies:  
a) Magnetic Resonance Imaging (MRI): 
All the groups were subjected to an MRI of 1.5 Tesla unit (Magnetom Symphony, 
Siemens, Version VA 12A) using a head coil. MRI protocol included: axial T1-WI; 
sagittal T2-WI and coronal FLAIR images. 
The left and right Caudate nuclei volume was measured. The volumes of 10 
subjects were calculated five times on the same scan by two raters to determine the 
test reliability. All volumes were measured by the raters without knowing the 
diagnosis or MRS measures. The volume of the caudate was calculated according 
to manual tracing technique (20,21).  
B) Magnetic Resonance Spectroscopy (MRS): 
Single-voxel localization proton MRS was performed using a spin-echo mode 
sequence. Two voxels (15x15x15) were placed on either right and left caudate .The 
raw data were transferred to an off-line workstation and post-processed 
automatically using a spectroscopic analysis package. Three main metabolites were 
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identified:  NAA at 2.0 parts per million (ppm), creatine at 3.0 ppm and choline at 
3.2 ppm. The peak ratios were calculated from the integration of the single peak 
including NAA /Creatine , NAA/Choline and Choline/Creatine. 
Statistical analysis: 
The results were computed on an IBM compatible personal computer Pentium IV 
using Statistical Software Package for Social scientists (SPSS) for windows 11 
(SPSS Inc., Chicago, IL, USA). Data were summarized using mean, median, 
standard deviation (SD) for quantitative data. The qualitative data were described 
as number and percent. 
Chi-square, chi-square with Yates’ correction and relative risks was used to test for 
association between different categorical variables (qualitative data). The 
difference between groups were tested using t-test for two group comparison and 
one way ANOVA for analysis of co-variance in more than two groups and post 
Hoc multiple comparisons test (Scheffe test) for within groups paired comparison 
(quantitative data). The correlation between two continuous groups was assessed 
using the Pearson’s correlation test. P value is considered significant if ≤ 0.05; and 
highly significant if ≤ 0.001 at confidence interval 95%. 
RESULTS 
Socio-demographic results 
All socio-demographic results are presented in Tables (1) and (2). Schizophrenic 
patients with OCS are more likely to live alone, with poorer occupational 
functioning even that they were of higher education level than schizophrenic 
patients without OCS (Table 1). 
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Eighty five percent of schizophrenic patients with OCS were right-handed and 70% 
of schizophrenic patients without OCS were right-handed with no statistically 
significant difference (P=0.449) (Table 1).  
Regarding the disease duration, the  mean duration of illness is more among 
schizophrenic patients with OCS (8.65 +/- 6.53 years) compared to schizophrenic 
patients without OCS (6.0 +/- 2.22 years)  with no statistical significant difference 
(P= 0.099) (table1) 
Concerning the age of onset, 55% of schizophrenic patients with OCS have the 
onset of the disorder before 15 years old in comparison to 25% of schizophrenic 
patients without OCS who developed the disease earlier than 15 years old. Forty 
percent of schizophrenic patients with OCS have age onset between 15-30 years 
old in comparison to 50% of schizophrenic patients without OCS. While only 5 % 
of schizophrenic patients with OCS have age onset from 35 to 45 years old 
compared to 25% of schizophrenic patients without OCS who have the same age of 
onset. The difference in overall age of onset is not statistically significant 
(P=0.066) but Chi-square for trend shows significant difference between both 
groups at age onset before 15 years old (P=0.043) (Table 2) 
Caudate Nucleus Volume Results: 
The size of caudate nucleus was significantly reduced in schizophrenic patients 
with OCS compared to schizophrenic patients without OCS and controls on both 
sides (left; P= 0.010 and right; P= 0.000) (Table 3). 
Magnetic Resonance Spectroscopy Results: 
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Choline values are statistically significantly higher in schizophrenia with and/or 
without OCS than controls at both sides (left; P=0.000 and right; P=0.042). A 
similar significant choline values are detected in the dominant hemisphere 
(P=0.000) (Table 4). 
The choline /creatine ratio significantly increases in schizophrenia with and/or 
without OCS than controls on the left side (P=0.000) while it increases on right but 
not statistically significant (P=0.223). A similar significant choline/creatine values 
are detected in the dominant hemisphere (P=0.000) (Table 4)   
The NAA values is significantly lower in schizophrenia with OCS than 
schizophrenia without OCS and controls on the left side (P=0.040) while it 
decreases on right but not with statistical significance (P=0.806). Also, these 
differences are not significant regarding the dominant hemisphere (P=0.187) 
(Table 4) 
A similar results were obtained regarding NAA /creatine ratio which was 
statistically significant low in schizophrenia with and without OCS than controls on 
the left (P=0.000) and dominant hemisphere (P=0.000), while statistically 
insignificant low on the right side (P=0.989). (Table 5) 
Choline /NAA ratio was significantly high in schizophrenia without OCS than 
schizophrenia with OCS and controls on the left (P=0.001) and dominant 
hemisphere (P=0.000) with higher values in schizophrenia with OCS , while 
statistically insignificant low on the right side (P=0.059) again with higher values 
in schizophrenia with OCS. (Table 5) 
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DISCUSSION 
In the present study we performed a volumetric assessment and MRS study on the 
caudate nucleus to investigate if there are possible underlying structural and 
functional differences between the schizophrenic patients with and without OCS. 
Our results for the handedness showed that 85% of schizophrenic patients with 
OCS were right handed and 15% were non-right handed (left handed and mixed 
handed). On the other hand, the schizophrenic patients without OCS showed more 
tendencies to be left handed (70% right handed and 30% non right handed). It is 
important to note that right-handedness, left cerebral dominance for language and 
normal cerebral asymmetry are considered to be secondary to a dominant allele, the 
‘right-shift factor’ (23). In schizophrenia, several studies reported an excess of non-
right handedness, decreased language lateralization on the dichotic listening 
paradigm (24) and decreased anatomical asymmetry (25). It has been postulated 
that the genetic mechanism underlying normal left hemispheric dominance is 
altered in schizophrenia. The discovery of the ‘right-shift factor’ might identify a 
locus where genetic aberrations predispose for schizophrenia (26). The difference 
between both groups of schizophrenic patients either with or without OCS as 
regard the handedness may support the idea of being different disorders with 
different genetic predisposition. 
Concerning the age group, our results showed that the age of about half of all 
schizophrenic patients with OCS were below 30 years old in comparison to one 
third of schizophrenic patients without OCS. This can be justified by the earlier 
onset of symptoms:  55% of schizophrenic patients with OCS has an age of onset 
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below 15 years old in comparison to 25% of schizophrenic patients without OCS 
with a statistically significant difference. 
The age of onset in 95% of schizophrenic patients with OCS was below 30 years 
old in comparison to 75% of schizophrenic patients without OCS. This may be 
explained by the denial of illness from nearby persons to the patients and decreased 
knowledge about psychiatric illness resulting in late discovery of the disease. On 
the other hand, the distressing effect of OCS in schizophrenia may be triggering for 
early seek for help and treatment.  
Regarding the volumetric assessment of the caudate nucleus, it was reduced in both 
schizophrenic groups compared to controls on both sides. This result is constant 
with (5,21) whereas, Brandt (9) described an increased in caudate volume in 
chronic schizophrenic patients. Data from longitudinal studies suggest that 
neuroleptics may change the brain morphology and these changes are dynamic and 
might be reversible. Nevertheless, several longitudinal studies have described a 
greater degree of brain tissue volumes decrease in the early stage of the illness but 
others have failed to confirm these findings (27). Thus, it remains unclear to what 
extent the observed structural changes reflect the ongoing illness process and to 
what extent the type and the duration of antipsychotic medication can modify the 
neuro-imaging measures. 
When we studied the caudate volume in OCD patients, we found only one study 
which described an increased of the gray matter volume in the head of the left 
caudate (28), and another one failed to show significant differences in caudate 
volumes between OCD patients and controls (29). On the contrary, many studies 
showed reduction in caudate volume of OCD patients (30,31). Based on this 
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confluent data, we can say that our caudate volume results need further studies on 
larger groups of patients involving schizophrenic and OCD patients under different 
types of medication for better evaluation of the results. 
Nevertheless, many neurodegenerative disorders such as Parkinson’s disease ( PD) 
and Huntington's disease (HD) are associated with neuropsychiatric symptoms such 
as OCS, impulse control, depression (32) and psychotic symptoms (33). 
Interestingly, a recent study showed that pre manifest HD exhibit small volume of 
the caudate nucleus (34,35). These recent studies highlight the need of further 
researches on the functional circuit dysfunction described in many neuropsychiatric 
disorders for better evaluation and early management.  
The MRS results in our study showed an increase in choline concentration in 
schizophrenia with or without OCS in comparison to controls. The choline 
concentration is higher in absence of OCS. This is in agreement with (13) (14) (15) 
who found significant higher levels of choline than the comparison subjects. 
Similar results were found in choline /creatine ratio which is in agreement with 
Gao and his colleagues (36) who found that the NAA /creatine and choline/creatine 
ratios were lower in the frontal cortex bilaterally among patients with 
schizophrenia , higher NAA/creatine ratio in the left frontal lobe, and a higher 
choline/creatine ratio in the right caudate. The latter finding was observed in our 
study but in left caudate. 
The NAA concentration is markedly reduced among schizophrenic patients with 
OCS than controls and schizophrenic patients without OCS. This is constant with 
older results (16,17,37). Meanwhile, Grošić V (38) revealed a significant rise in the 
NAA/Creatine level in the studied group that stayed on the same antipsychotic 
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treatment and a significant drop in NAA/Creatine in the studied group that 
switched the antipsychotics. In our study we did not address the effect of 
medications as all our patients were drug naïve.     
Schizophrenic patients without OCS showed relative increase in NAA 
concentration either in left or dominant caudate nucleus while they showed more or 
less similar NAA concentration as controls in right hemisphere which is in 
agreement with (39).  
The NAA /creatine ratio is markedly reduced among schizophrenic patients with 
OCS and to less extent in schizophrenic patients without OCS than controls which 
is congruent with other authors (16,17,39,40). The increase in choline to NAA ratio 
in patients with or without OCS in comparison to controls is in agreement with 
different studies (13,39, 41). 
NAA is considered to reflect both, neuronal density and integrity of neuronal 
mitochondria. Thus, reduction of NAA may represent diminished neuronal 
integrity (41) or an altered functional (metabolic) state of neurons (42). This 
functional finding was described in other psychiatric disorders and recent studies 
reported reversal of decreased NAA concentration with treatment reflecting a 
functional restoration (42). 
Deicken and co-authors (43) stated that the most consistently replicated findings in 
schizophrenia are reduced NAA measures in the hippocampal regions while, this 
finding is less consistent in the frontal cortex, basal ganglia, cingulate region, and 
thalamus in schizophrenia. Furthermore, there are no consistently replicated 
findings for choline or creatine alterations in any of the brain regions examined in 
schizophrenia. 
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Recently, Dengtang and his colleagues (36) found a decreased NAA/Creatine ratio 
in the prefrontal cortex among schizophrenic patients. However, most studies found 
no significant changes in the Choline/Creatine ratio. These findings support the 
hypothesis of the early damage of neurons in the frontal cortex and fronto-striatal 
connection in the individuals with schizophrenia.  
Choline has been proposed as a marker for neuronal astrocytosis associated with 
neurodegenerative diseases and other brain injury (44). Elevated Creatine suggests 
abnormal local cell-energy demand and elevated Choline suggests a phospholipid 
membrane disturbances in patients with early age-of-onset schizophrenia (41).  
Schizophrenic patients with OCS may be a disorder with two pathologies 
(schizophrenia with normal NAA level and OCD with decreased NAA level as 
postulated by  Bartha and others (17, 18,45).The more reduction of NAA in caudate 
nucleus in schizophrenic patients with OCS than schizophrenic patients without 
OCS could be explained by the idea that schizophrenic patients without OCS is one 
disorder with one pathology  referring to Bustillo (37) who showed that 
schizophrenia alone is associated with normal level of NAA.  
CONCLUSION 
Schizophrenic patients with OCS may have an atypical set of neuro-radiological 
characteristics which is reflected on the clinical presentation and perhaps it 
constitutes a subgroup within the schizophrenia spectrum. More researches on a 
larger group of patients are warranted for optimal categorization of those patients. 
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Figure legends:  
(Fig.1): MRS of schizophrenic patient without obsessive compulsive symptoms 
showing marked increase in choline concentration (8.92ppm) while the N-acetyl 
aspartate concentration is of average range (12.5ppm). 
(Fig.2): MRS of schizophrenic patient with obsessive-compulsive symptoms 
showing marked decrease in N-acetyl aspartate concentration (3.56ppm) while 
choline concentration is of average range (3.99ppm).  
(Fig.3): MRS of control subject showing average concentration of choline 
(3.65ppm) and N-acetyl aspartate (12.5ppm). 
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 الملخص العربي
 
 :المقدمة
لقد لوحظ تواجد أعراض الوسواس القهرى في مرضى الفصام بشكل متفاوت و بالرغم من ذلك 
م ,أفإن البحوث لم تستطع تحديد هل أعراض الوسواس القهرى مجرد ملازمة لأعراض الفصام 
 .إنها نوع خاص من أنواع الفصام المختلفة 
 الهدف من الدراسة:
مرض الفصام المصحوب وغير  بين ظيفيةأو و اختلافات هيكلية إذا كان هناكالبحث 
 .المصحوب بأعراض الوسواس القهرى
 الوسائل:
تم تقسيم المشاركين في هذا البحث إلى ثلاث مجموعات وهي مجموعة الفصام المصحوب 
ومجموعة الفصام الغير مصحوب بأعراض الوسواس 20بأعراض الوسواس القهرى وعددهم 
هاتين المجموعتين اكلينيكيا و تشخيصهم باستخدام الدليل فحص قد تم و 20 القهرى وعددهم
و أخيرا العينه الضابطه وعددهم أيضا  لتشخيص الأمراض النفسيه الرابع المعدلالأمريكي 
  .20
جميع المشاركين بالبحث خضعوا للرنين المغناطيسي لقياس حجم النواة الذيلية و الرنين 
النواة فى  يل اسبرتاتيتن و الكرياتين و الان اسمعدلات الكولياس المغناطيسي الطيفى لقي
 .الذيلية
 :النتائج
دراسة أن حجم النواة الذيلية صغير في مرضي الفصام َمع َأو بدون أعراض الأوضحت  
 .الوسواس القهري مقارنه بالعينه الضابطه
مرضى الفصام بدون أعراض الوسواس القهري  كما أوضح الرنيَن المغناطيسَي الطيفي أن
مع الاحتفاظ بالمعدل الطبيعي لتركيز ,لديهم زيادة هامة و دالة إحصائيا في تركيز مادة الكولين 
مادة الإن أسيتيل اسبرتات. و من الناحية الأخرى فأن مرضى الفصام مع أعراض الوسواس 
هام و دال إحصائيا مع الاحتفاظ هوو القهري لديهم تركيزًا اقل لمادة إن أسيتيل اسبرتات 
 بالمعدل الطبيعي لتركيز مادة الكولين. 
  الاستنتاج:
ص ئخصا لها قد يكون  المصحوب بأعراض الوسواس القهرى مرضى الفصام ةمجموع ان 
 .الفصام داخل طيف ها كمجموعه فرعيه محددهتصنف إشعاعية مختلفه من شأنها أن عصبية
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Tables 
 
Table (1): The socio-demographic data among the studied groups 
 
Variable 
 
Schizophrenia with 
OCS 
Schizophrenia 
without OCS 
X2 P R.R. 
Number (%) Number(%)    
Sex Male 15 (75%) 12 (60%) 1.026 0.311 1.444 
Female 5(25%) 8(40%) 
Handedness Non right 3 (15%) 6(30%) 0.573 0.449 0.722 
Right 17(85%) 14(70%) 
Marital 
status 
Single 15(75%) 11(55%) 4.868 0.088 0.608 
Married 5(25%) 6(30%) 
Divorced 0 (0%) 3(15%) 
Widow 0(0%) 0(0%) 
Occupation Not working** 12(60%) 10(50%) 7.141 0.068 1.476 
Student** 3(15%) 1(5%) 
Semi-skilled** 3(15%) 8(40%) 
Skilled** 2(10%) 1(5%) 
Education <6 years** 3(15%) 9(45%) 6.134 0.047* 1.333 
6-12 years** 10(50%) 9(45%) 
>12 years** 7(35%) 2(10%) 
Residence Rural 16 (80%) 14(70%) 0.533 0.465 0.778 
Urban 4(20%) 6(30%) 
Duration  Mean (SD) 
8.65 (±6.53) 
6.00(±2.22) 1.718 0.099  
 
OCS=obsessive compulsive symptoms 
** Classification according to UK National Statistics Socio-Economic Classification (22)   
* Statistically significant difference  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table
  
Table (2): Age and age of onset distribution among the studied groups 
 
Age Schizophrenia 
with OCS  
Number (%) 
 
Schizophrenia 
without OCS  
Number (%) 
X2 for 
Trend 
P R.R. X2 P 
<15 0(0%) 0(0%) 0 0   
 
 
 
2.543 
 
 
 
 
0.280 
15-30 10(50%) 6(30%) 1.66 0.197 1.49 
0.642 
30-45 7(35%) 12(60%) 2.51 0.113 0.595 
1.65 
>45 3(15%) 2(10%) 0.229 0.633 1.23 
0.777 
Age 
Of 
onset 
 
0-15 
11(55%) 5(25%) 3.75 0.043* 
1.834  
 
 
 
5.44 
 
 
 
 
 
0.066 
 
0.5 
15-30 
8(40%) 10(50%) 0.404 0.525 
0.814 
1.22 
30-45 
1(5%) 5(25%) 1.765 0.184 
0.298 
1.89 
>45 
0(0%) 0(0%) 
   
 
 
 
OCS=obsessive compulsive symptoms  
** Correlation is significant at at P ≤ 0.001 level (2-tailed). 
* Correlation is significant at≤ 0.05 level (2-tailed). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table (3): Caudate size among studied groups 
 
Overall comparison (One way ANOVA) Post Hoc Multiple comparisons test (Scheffe test) 
  Controls Schizophrenia 
with OCS 
Schizophrenia 
without OCS 
P Controls/schizophrenia 
with OCS 
Controls/schizophrenia 
without OCS 
Schizophrenia with 
OCS/schizophrenia 
without OCS 
Rt 
caudate 
Mean 5.41416 3.91782 4.10193 
0.000** 
Mean 
differences 
P Mean 
differences 
P Mean 
differences 
P 
SD 0.612240 0.398860 0.415288 0.880200 0.000** 0.771900 0.000** -0.10830 0.732 
Lt 
caudate  
Mean 5.56818 4.21209 3.862791 0.003* 
Mean 
differences 
P Mean 
differences 
P Mean 
differences 
P 
SD 0.617961 0.918221 0.533191  0.797700 0.018* 1.003170** 0.002* 0.205470 0.647 
 
OCS=obsessive compulsive symptoms, Rt= right, Lt=left, SD= standard deviation 
** Correlation is highly significant at P ≤ 0.001 level (2-tailed). 
* Correlation is significant at P ≤ 0.05 level (2-tailed). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4): Brain metabolites among the studied groups 
 
Post Hoc Multiple comparisons test (Scheffe test) Overall comparison (One way ANOVA) MRS 
parameter 
Schizophrenia with 
OCS/schizophrenia 
without OCS 
Controls 
/schizophrenia 
without OCS 
Controls 
/schizophrenia 
with OCS 
P Schizophrenia 
without OCS 
Schizophrenia 
with OCS 
Controls   
P Mean 
differences 
P Mean 
differences 
P Mean 
differences 
0.000** 
5.36150 4.06000 3.21200 
Mean Lt Cho 
0.017* -1.3015 .001** -2.149 0.292 -0.84800 1.89500 0.84360 0.91146 SD 
0.574 -.48100 .042* -1.447 0.231 -0.96650 
0.042* 5.12550 4.64450 3.67800 Mean Rt Cho 
1.37384 1.71119 0.76405 SD 
0.000** -1.903 0.000** -2.75 0.233 -0.85450 
0.000** 6.00550 4.10250 3.24800 Mean Dominant 
Cho 1.74433 0.84126 0.73635 SD 
0.000** -0.2346 
 
0.001** 
 
-0.26260 
 
0.910 
 
-0.28820 
 
0.000** 
0.76535 0.53073 0.50270 Mean Lt Cho/ Cr 
0.18193 0.14036 0.18126 SD 
0.545 -0.15946 
 
0.246 
 
-0.29966 
 
0.730 
 
-0.14020 
 
0.223 
0.87966 0.72020 0.58000 Mean Rt Cho/ Cr 
0.55075 0.44703 0.13539 SD 
0.000** 
-0.3357 0.000** -0.3438 0.991 -0.81803 0.000** 
0.88850 0.55279 0.54470 Mean Dominant 
Cho/ Cr 0.16895 0.14539 0.13893 SD 
0.121 -1.65600 
 
0.844 
 
0.56350 
 
0.082 
 
2.21950 
 
0.040* 
11.19250 9.53650 11.75600 Mean Lt  NAA 
1.23117 3.40508 2.18776 SD 
0.814 -.67600 
 
0.926 
 
-0.50450 
 
0.991 
 
0.17150 
 
0.806 
11.41550 10.73950 10.91100 Mean Rt NAA 
3.06416 3.66938 3.10340 SD 
0.189 
-1.58900 0.821 -0.65950 0.677 0.92950 0.187 
11.12550 9.53650 10.46600 Mean Dominant 
NAA 
1.30007 3.40508 3.18195 SD 
 
OCS=obsessive compulsive symptoms, Rt= right, Lt=lef, SD= standard deviation t, Cho=choline, Cr= creatine, NAA+N-acetyl 
aspartate 
** Correlation is highly significant at P ≤0.001 level (2-tailed). 
* Correlation is significant at P ≤0.05 level (2-tailed). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (5): N-acetyl aspartate /Creatine and choline / N-Acetyl aspartate among 
studied groups. 
  
Post Hoc Multiple comparisons test (Scheffe test) Overall comparison (One way ANOVA) NAA /Cr 
Schizophrenia with 
OCS/schizophrenia 
without OCS 
Controls 
/schizophrenia 
without OCS 
Controls 
/schizophrenia with 
OCS 
P Schizophrenia 
without OCS 
Schizophrenia 
with OCS 
Controls   
P Mean 
differences 
P Mean 
differenc
es 
P Mean 
differenc
es 
0.000** 
1.57950 1.04750 1.73350 
Mean Lt 
0.014* -0.3491 0.217 0.24895 0.000** 0.59805 0.426702 0.10992 0.25239 SD 
0.990 -0.42802 1 
-
0.28803 
0.994 -0.39802 0.989** 
1.68900 1.67850 1.87450 Mean Rt 
1.21372 0.83247 0.36182 SD 
0.026* -0.3899* 0.001** 0.67020 0.000** 1.06015 0.000** 
1.62900 1.04750 2.03450 Mean Dominant 
0.62702 0.10992 0.57927 SD 
 Cho / 
NAA 
0.953 
 
1.46802 
 
0.002* 
 
-0.213 
 
0.001** 
 
-0.2283 
 
0.001** 
0.49950 0.51410 0.28580 MeanLt 
0.14036 0.17817 
8.7092E-
02 
SD 
0.594 
 
-0.353802 
 
0.059 
 
-
0.10332 
 
0.282 
 
-0.67802 
 
0.059 
0.42875 0.39340 0.32543 MeanRt 
0.11488 0.11447 
7.9853E-
02 
SD 
0.746 -0.32802 0.000** -0.2687  0.000** -0.2367 0.000** 
0.55275 0.52080 0.28403 MeanDominant  
0.10298 0.17408 
6.3816E-
02 
SD 
 
 
OCS=obsessive compulsive symptoms, Rt= right, Lt=lef, SD= standard deviation t, Cho=choline, Cr= creatine, NAA=N-acetyl 
aspartate 
** Correlation is highly significant at P ≤ 0.001 level (2-tailed). 
* Correlation is significant at P ≤ 0.05 level (2-tailed). 
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